Federico Monaca

💡We are delighted to highlight Dr Federico Monaca @fede_monaca as a touchONCOLOGY Future Leader 2026 In this interview, he reflects on mentorship, the value of patience in research & the evolving role of next-generation immunotherapies in oncology Read: touchoncology.com/insight/fl-fed…

Great discussions at the EORTC Lung Cancer Group meeting in Gdańsk. A real privilege to work with such a collaborative and forward-thinking community—especially encouraging to see new voices actively contributing to study design and research priorities. You are welcome!! #EORTC

Announcing the touchONCOLOGY Future Leaders 2026 - early-career clinicians & researchers making an impact: touchoncology.com/insight/meet-t… @amerseburger @ElisaAgostinett @DulalSoniya @oncology_bg @DarrenHaywood14 @lenzgabriel_md @KevinKeane92 @fede_monaca @JGomezRivas @MargaretWheless

📄 Our review in @JTOonline is now out: Antibody–Drug Conjugates in Small-Cell Lung Cancer: DLL3, B7-H3, TROP2 and Beyond DOI: 10.1016/j.jtho.2026.103726 Key question: not just whether ADCs work in relapsed #SCLC, but how to sequence them with DLL3-directed T-cell engagers.

ELCC 2026 was a truly special and emotional meeting for me. Honoured to receive a Merit Award, and grateful to everyone who supported me along the way. #ELCC2026 #ESMO @myESMO

Another #BTOG wrapped up — and once again it showed why it remains such an important multidisciplinary congress. A great chance to bring specialties together from across the UK, share ideas, learn from each other, and keep pushing the field forward. @marialuciareale

⭐ Just wrapped up a 9-session leadership development course with EORTC. New perspectives on leadership in research & clinical trials, plus practical tools for communication, collaboration & decision-making. Grateful for such a useful and energising programme. #EORTC

🌟 WCLC 2025: Dr Federico Monaca (The Christie NHS Foundation Trust, UK) shares insights on consolidative thoracic radiotherapy (cTRT) in ES-SCLC, plus highlights in DLL3-targeted therapies & novel immunotherapy. 👉 touchoncology.com/insight/consol… @fede_monaca #WCLC2025 #LungCancer

Just wrapped up an energising #WCLC2025! 🎯 Deep dives into FLAURA-2, the HARMONi trial, and momentum around new ADCs in SCLC. 🚀 Wonderful to reconnect with colleagues worldwide. 🌍 #LungCancer #EGFR #ADC #SCLC @HHorinouchi